Increasing Access to new Under-Used Vaccines in GAVI-eligible ACP countries EDF10 - ACP-EU (Intra-ACP programmes) implemented in ACP Member States and Regions.

Agreement No.REG/FED/22024-Increasing Access to new Under-Used Vaccines in GAVI-eligible ACP countries was signed on 8 February 2012 for an amount of €20.0 million.

https://www.gavi.org/

Implementation Mode:

A Grant Contract has been signed between the EC and GAVI for the implementation of the action.

Objective

The Programme’s objective is to improve and sustain increased immunization coverage in GAVI-eligible ACP countries benefiting from GAVI support through the procurement and delivery of pentavalent vaccines, including DTP, Hep B and Hib on the basis of country applications approved by GAVI for the years 2011-2012.

Expected Results are as follows:

Pentavalent vaccines provided to MoHs, in accordance with each country proposal;
Improved and/or sustained national immunization rates against the diseases targeted by the pentavalent vaccines.

The programme is ongoing

GAVI continues to provide reports to the Sub-Committee on Sustainable Development

Beneficiary ACP countries:

Angola, Benin, Burkina Faso, Burundi, Cameroon, CAR, Chad, Comoros, Congo, DRC Cote d’Ivoire, Djibouti, Eritrea, Ethiopia, Gambia, Ghana, Guinea, Guinea Bissau, Guyana, Haiti, Kenya, Kiribati, Lesotho, Liberia, Madagascar, Malawi, Mali, Mauritania, Mozambique, Niger, Nigeria, PNG, Rwanda, Sao Tome & Principe, Senegal, Sierra Leone, Solomon Islands, Somalia, S. Sudan, Sudan, Tanzania, Timor Leste, Togo, Uganda, Zambia, Zimbabwe.

For more information, contact: Department of Political Affairs and Human Development (PAHD)

Increasing Access to new Under-Used Vaccines in GAVI-eligible ACP countries / EDF10 REG/FED/22024

Increasing Access to new Under-Used Vaccines in GAVI-eligible ACP countries / EDF10
REG/FED/22024